Concepedia
Statistics
Publications
5
Citations
1.5K
H-Index
Active since
2002
Affiliations
Brigham and Women's Hospital(Current)
National Institutes of Health
Harvard University
Center for Cancer Research
Dana-Farber Cancer Institute
David I. Hong is an author at Brigham and Women's Hospital specializing in medicine, cancer chemotherapy, and oncology.
Top concepts
MedicineOncologyChemotherapyPharmacologyImmunotherapyPharmacotherapyCancer ChemotherapyAllergyToxicologyCell Biology
Publications per year
2002–2016
T cell receptor ligation induces the formation of dynamically regulated signaling assemblies
Stephen C. Bunnell, David I. Hong, Julia R. Kardon et al. · The Journal of Cell Biology · 2002 · 612 citations · Full text
Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
Mariana Castells, Nichole M. Tennant, David E. E. Sloane et al. · Journal of Allergy and Clinical Immunology · 2008 · 579 citations
Drug Hypersensitivity, Drug Intolerance, Allergy +14
Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies
David E. E. Sloane, Usha Govindarajulu, Jacob Harrow-Mortelliti et al. · The Journal of Allergy and Clinical Immunology In Practice · 2016 · 202 citations
Preclinical Drug Evaluation, Medicine, Pharmacology +11
Persistence of Cooperatively Stabilized Signaling Clusters Drives T-Cell Activation
Stephen C. Bunnell, Andrew L. Singer, David I. Hong et al. · Molecular and Cellular Biology · 2006 · 117 citations · Full text
T-regulatory Cell, Antigen Recognition, Molecular Biology +16
Inhibition of Th2 Adaptive Immune Responses and Pulmonary Inflammation by Leukocyte Ig-Like Receptor B4 on Dendritic Cells
Rebecca G. Breslow, Jayanti Rao, Wei Xing et al. · The Journal of Immunology · 2009 · 14 citations · Full text
1–5 of 5